Disclosed are compounds, compositions and methods for treating viral infections, diseases, syndromes, or disorders that are affected by the modulation of STING. Such compounds are represented by Formula (I) as follows: [Formula (I) should be inserted here] wherein R1A, R1B, R1c, B1, R2A, and R2B are defined herein.